These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32583902)

  • 21. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases.
    Alam M; Arndt KA; Dover JS
    J Am Acad Dermatol; 2002 Jan; 46(1):62-5. PubMed ID: 11756947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of sphenopalatine ganglion neuroablation in the management of cluster headache.
    Narouze SN
    Curr Pain Headache Rep; 2010 Apr; 14(2):160-3. PubMed ID: 20425206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum Toxin Type-A (Botulax
    Kim H; Jang B; Kim ST
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34064451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study.
    García-Azorín D; Trigo-López J; Sierra Á; Blanco-García L; Martínez-Pías E; Martínez B; Talavera B; Guerrero ÁL
    Cephalalgia; 2019 Dec; 39(14):1818-1826. PubMed ID: 31272194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
    Jochim A; Meindl T; Huber C; Mantel T; Zwirner S; Castrop F; Haslinger B
    J Neurol; 2020 Jan; 267(1):267-275. PubMed ID: 31630241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study.
    Winner PK; Blumenfeld AM; Eross EJ; Orejudos AC; Mirjah DL; Adams AM; Brin MF
    Drug Saf; 2019 Aug; 42(8):1013-1024. PubMed ID: 31102144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Bilateral Sphenopalatine Ganglion Stimulation for Intractable Bilateral Chronic Cluster Headache: A Case Report.
    Meng DW; Zhang JG; Zheng Z; Wang X; Luo F; Zhang K
    Pain Physician; 2016 May; 19(4):E637-42. PubMed ID: 27228531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botox treatment for migraine and chronic daily headache in adolescents.
    Chan VW; McCabe EJ; MacGregor DL
    J Neurosci Nurs; 2009 Oct; 41(5):235-43. PubMed ID: 19835236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical course of patients with episodic cluster headache treated with corticosteroids inproximity to the sphenopalatine ganglion: a preliminary study of 23 patients.
    Peñarrocha-Diago M; Boronat A; Peñarrocha-Oltra D; Ata-Ali J; Bagan JV; Peñarrocha-Diago M
    Med Oral Patol Oral Cir Bucal; 2012 May; 17(3):e477-82. PubMed ID: 22143727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks.
    Jost WH; Friedman A; Michel O; Oehlwein C; Slawek J; Bogucki A; Ochudlo S; Banach M; Pagan F; Flatau-Baqué B; Dorsch U; Csikós J; Blitzer A
    Parkinsonism Relat Disord; 2020 Jan; 70():23-30. PubMed ID: 31794936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
    Zhang H; Lian Y; Ma Y; Chen Y; He C; Xie N; Wu C
    J Headache Pain; 2014 Sep; 15(1):65. PubMed ID: 25263254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial.
    Leroux E; Valade D; Taifas I; Vicaut E; Chagnon M; Roos C; Ducros A
    Lancet Neurol; 2011 Oct; 10(10):891-7. PubMed ID: 21903477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicentre, prospective, randomised, controlled, blinded-endpoint study to evaluate the efficacy and safety of pterygopalatine ganglion pulsed radiofrequency treatment for cluster headache: study protocol.
    Li J; Ren H; Wang B; Wu D; Luo F
    BMJ Open; 2019 Mar; 9(3):e026608. PubMed ID: 30904875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OnabotulinumtoxinA in the treatment of refractory chronic cluster headache.
    Lampl C; Rudolph M; Bräutigam E
    J Headache Pain; 2018 Jun; 19(1):45. PubMed ID: 29915913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
    Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD
    Acta Neurol Scand; 2014 Jan; 129(1):61-70. PubMed ID: 24107267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headache.
    Erdemoglu AK; Varlibas A
    J Headache Pain; 2007 Oct; 8(5):294-300. PubMed ID: 17955170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short and Mid-Term Predictors of Response to OnabotulinumtoxinA: Real-Life Experience Observational Study.
    Alpuente A; Gallardo VJ; Torres-Ferrús M; Álvarez-Sabin J; Pozo-Rosich P
    Headache; 2020 Apr; 60(4):677-685. PubMed ID: 32086801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.